Pharmaceutical industry and biotechnology Why Belarus? 1 ...

lunchlexicographerΒιοτεχνολογία

1 Δεκ 2012 (πριν από 5 χρόνια και 1 μήνα)

263 εμφανίσεις

P
harmaceutical industry

and biotechnology

Why Belarus?

1.

Pharmaceutical

and

biotech

industries

development

is

a

priority for

the state. To

stimulate

the

industries

growth a
range of
government programs

was adopted
:



Program for innovative development in

2011


2015



Program


Innovative

biotechnologies


till 2015



P
rogram

for

import

substitution

of

pharmaceutical

substance
s

and

products till 2020
.

2.

The

enterprise

located

in

Belarus

can

easily

be

oriented

toward

the

pharmaceutical market

of

Common economic
space

(its size in 2011 was
$24.8
bln) and
CIS market

(sized

$29.6
bln
1

in 2011
).

3.

The possibility of investment agreement with the Republic of Belarus which provides significant benefits
for
investor
s
.

4.

Unique conditions

for

innovative

biotech
/
pharmaceutical

enterprises and start
-
ups within the scientific and
technological park “
BelBiograd
”.

5.

Human

resources

for

biotech/pharmaceutical industry development:




Specialists

for

the

industries

are trained by the country’s leading educational
institutions: Belarusian State
University, Belarusian State Technological University, Vitebsk State Medical University etc.




3.2
thousand

life sciences students

to

be

trained

by

Belarusian

i
nstitute
s

of higher education
in 2012
-
2015
.



7500
people employed
in biopharmaceutical industry


Scientific and technological park “BelBiograd”

Is

a

technopolis

which

provides

all the

necessary conditions

for

a

complete

cycle

of

innovative activities form R&D to
the production stage.

Benefits for the residents:



Tax

exemption
(
corporate

tax
,
real estate tax
,
land tax
,
local taxes
)



Custom

duties

exemption (the entry of equipment

and component parts for investment projects
implementation)



State

due

exemption

(
foreign

labour

force

hiring
)



Simplified administrative
procedures

There

is

a

search

for

founder
s

of


BelBiograd

managing

company
.

Growth potential of the industries






1

“Farmexpert” Market research center data

-
Belarus is ranked 3rd among CIS countries and Georgia by average per capita consumption of
pharmaceutical products in
2011
-
$66.5
-
more than 30 companies are involved in the production of pharmaceutical products, the share
of local products at the domestic market was
24.9%
in
2011
in value terms.
Export of Belarusian
pharmaceuticals to Russia and Kazakhstan
totalled $95.9 mln
-
in
2011
the government spending for healthcare in Belarus was
5.8%
of GDP and 8.8% of total
government spending
,
according to WHO data
-
mutual recognition of pharmaceuticals registration certificates of GMP
-
certified manufacturers
within Common economic space from 2013
-
progressive unification of pharmaceutical circulation laws with
EU standarts
-
scientific potential of biotech industry
:
National Academy of Sciences and Universities of the
country work on genomic biotechnologies, biotechnologies for agricultural use (incl. veterinary
medicine)